Document

A University of Texas Southwestern Medical Center study has identified a new potential therapeutic target for controlling high blood sugar, a finding that could help the estimated 25 million Americans with type 2 diabetes.

Indiana University Kokomo will be well represented at the IU Medical School this fall, filling nearly half the class in one program.

Using a powerful data-crunching technique, Johns Hopkins researchers have sorted out how a protein keeps defective genetic material from gumming up the cellular works. The protein, Dom34, appears to “rescue” protein-making factories called ribosomes when they get stuck obeying defective genetic instructions, the researchers report in the Feb. 27 issue of Cell.

Cornell University researchers report they have discovered direct genetic evidence that a family of genes, called MicroRNA-34 (miR-34), are bona fide tumor suppressors.

Hopkins researchers improve modeling of movement in 3D environments, which could lead to better understanding of how metastasis occurs.

From the sun, a solution: Cornell University and Weill Cornell Medical College researchers have remodeled an energy-intensive medical test – designed to detect a deadly skin cancer related to HIV infections – to create a quick diagnostic assay perfect for remote regions of the world, according to Scientific Reports (Feb. 20), an online publication of Nature.

If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient’s cancer treatment on commonly disrupted genes and pathways.












